Procedural outcomes | |
---|---|
30 day all cause mortality | 5/88 (5.7%) |
1 year actuarial all cause mortality | 14/84 (16.7%) |
Kaplan Meier 1 year all cause survival | 83.3% |
Causes of death (1 year) * n = 14 | |
Sepsis | 3/14 (21.4%) |
Renal failure | 1/14 (7.1%) |
Pacing wire ventricular perforation | 1/14 (7.1%) |
Root rupture | 1/14 (7.1%) |
Myocardial infarction | 3/14 (21.4%) |
Congestive heart failure | 2/14 (14.5%) |
Stroke | 3/14 (21.4%) |
Cardiovascular death at 1 year | 10/84 (11.9%) |
Major Vascular complications | 8/88 (8%) |
Coronary obstruction | 2/88 (2.3%) |
30 day disabling stroke risk | 5/88 (5.7%) |
30 day Acute kidney injury with renal replacement therapy | 6/88 (6.8%) |
Device success rate (defined as single valve,with no moderate to severe PVL, mean gradient < 20 mmHg) | 88.6% |
1 year Prosthetic valve endocarditis | 2/84 (2.4%) |
1 year Repeat valvular intervention | 1/84 (1.2%) |
30 Day Pacemaker rates (n = 85 *3 cases of pre op PPM excluded) | 15/85 (17.6%) |
Moderate or more paravalvular leak (PVL) on 1 year echocardiogram | 5/84 (6.0%) |
Repeated cardiac events (angina, MI, heart failure) requiring admissions within 1 year | 7/84 (8.3%) |